Yatharth Hospital Reports Record Q3FY26 Results with 46% Revenue Growth

3 min read     Updated on 02 Feb 2026, 01:42 PM
scanx
Reviewed by
Ashish TScanX News Team
Overview

Yatharth Hospital & Trauma Care Services Limited delivered outstanding Q3FY26 performance with revenue reaching ₹3,205 million (46% growth) and profit after tax of ₹431 million (41% growth). New hospitals in Delhi and Faridabad contributed ₹279 million in revenue. The company has made its February 6, 2026 earnings call recording available on its website for transparency.

31565535

*this image is generated using AI for illustrative purposes only.

Yatharth Hospital & Trauma Care Services Limited has announced exceptional Q3FY26 quarterly results for the quarter ended December 31, 2025, showcasing industry-leading financial performance with record revenue growth. The healthcare provider delivered outstanding consolidated results with revenue from operations reaching ₹3,205 million compared to ₹2,192 million in the corresponding quarter of the previous year, representing substantial growth of 46%.

Outstanding Financial Performance

The company demonstrated remarkable financial metrics across all key parameters during Q3FY26. Consolidated profit after tax reached ₹431 million, marking a significant 41% increase from ₹305 million in Q3FY25. The company's EBITDA stood at a record ₹742 million, up 35% year-on-year, while maintaining healthy margins despite expansion activities.

Particulars: Q3FY26 Q3FY25 YoY Growth (%) Q2FY26 QoQ Growth (%)
Revenue (₹ mn): 3,205 2,192 +46% 2,794 +15%
EBITDA (₹ mn): 742 549 +35% 645 +15%
EBITDA Margin: 23.2% 25.1% -189 bps 23.1% +8 bps
Profit After Tax (₹ mn): 431 305 +41% 413 +4%

Strategic Expansion Driving Growth

The company's growth momentum was significantly driven by newly operational hospitals, with New Delhi and Faridabad Sec-20 contributing ₹279 million in revenue, representing 9% of the Group's revenues within their first full quarter of operations. These new facilities demonstrated strong performance with 100% of revenues derived from cash and TPA patients, reflecting the company's strategic focus on improving payer mix from day one of operations.

New Hospital Performance: Details
Combined Revenue Contribution: ₹279 million (9% of Group revenue)
Faridabad Sec-20 Monthly Run Rate: ₹7-8 crore
New Delhi Monthly Run Rate: ₹5 crore
Revenue Mix: 100% Cash & TPA, 0% Government
New Delhi ARPOB: ₹40,000
Faridabad Sec-20 ARPOB: ₹36,000

Nine-Month Performance and Operational Excellence

For the nine-month period ended December 31, 2025, the company maintained consistent growth with consolidated revenue reaching ₹8,577 million compared to ₹6,487 million in the corresponding previous period, representing 32% growth. The Group ARPOB witnessed continued momentum at ₹33,744, up 10% year-on-year, with Noida Extension recording its highest-ever ARPOB at ₹44,000, up 16% year-on-year.

Nine-Month Performance: 9MFY26 9MFY25 Growth (%)
Revenue (₹ mn): 8,577 6,487 +32%
Profit After Tax (₹ mn): 1,264 918 +38%
Group ARPOB: ₹33,744 - +10% YoY

Earnings Conference Call and Recording Availability

Following the announcement of Q3FY26 results on February 5, 2026, the management hosted a conference call on February 6, 2026, at 1:00 PM IST to discuss the performance and answer questions from participants. The company has now made the audio recording of the earnings call available on its website for stakeholder access and transparency.

Conference Call Information: Details
Date & Time: February 6, 2026 at 1:00 PM IST
Universal Dial-In: +91 22 6280 1123 / +91 22 7115 8024
Recording Access: www.yatharthhospitals.com/uploads/earningscallrecordingq3fy26.mp3
Investor Portal: www.yatharthhospitals.com/investors

Regulatory Compliance and Transparency

In compliance with SEBI regulations 30 and 47, the company published its Q3FY26 unaudited financial results in leading newspapers on February 6, 2026. The results were published in Financial Express (English) and Jansatta (Hindi) to ensure transparency and accessibility for all stakeholders. The complete financial results and earnings call recording are available on the company's website.

Publication Details: Information
Publication Date: February 6, 2026
English Newspaper: Financial Express
Hindi Newspaper: Jansatta
Website Access: www.yatharthhospitals.com/investors

Management Commentary and Future Outlook

Commenting on the performance, Mr. Yatharth Tyagi, Whole Time Director, highlighted the company's ability to successfully acquire, integrate, and scale new assets rapidly. He emphasized that the Agra facility, integrated from February 2026, is expected to contribute meaningfully from the current quarter. The Greater Faridabad hospital has turned profitable and is now adding significantly to Group financials, reflecting strong execution and clinical excellence.

Historical Stock Returns for Yatharth Hospital

1 Day5 Days1 Month6 Months1 Year5 Years
+2.70%-2.41%-1.19%-15.23%+80.28%+99.13%

Yatharth Hospital Executes Share Purchase Agreement for Agra Hospital Acquisition

1 min read     Updated on 29 Jan 2026, 01:40 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

Yatharth Hospital & Trauma Care Services Limited executed a Share Purchase Agreement on January 29, 2026, completing its 100% acquisition of Shantived Institute of Medical Sciences in Agra. Commercial operations at the acquired facility will begin February 1st, 2026. This follows the company's September 13, 2025 disclosure and represents continued expansion in the healthcare sector.

31219833

*this image is generated using AI for illustrative purposes only.

Yatharth Hospital & Trauma Care Services Limited has successfully executed a Share Purchase Agreement (SPA) on January 29, 2026, to complete its acquisition of 100% interest in Shantived Institute of Medical Sciences located in Agra. The company made this announcement through a regulatory filing under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.

Acquisition Timeline and Commercial Operations

The healthcare provider has outlined a clear timeline for integrating the acquired facility into its operations. Commercial operations at the target hospital are scheduled to commence from February 1st, 2026, marking a swift transition from agreement execution to operational launch.

Parameter: Details
Agreement Date: January 29, 2026
Acquisition Stake: 100% interest
Target Facility: Shantived Institute of Medical Sciences
Location: Agra
Operations Start: February 1st, 2026

Previous Disclosure and Regulatory Compliance

This latest development follows the company's earlier communication dated September 13, 2025, which initially disclosed the planned acquisition. The execution of the Share Purchase Agreement represents the culmination of the acquisition process that has been in progress for several months.

The company has ensured full regulatory compliance by filing the requisite disclosure with both the National Stock Exchange of India Limited and BSE Limited. The announcement was signed by Ritesh Mishra, Company Secretary & Compliance Officer, maintaining proper corporate governance protocols.

Expanding Healthcare Network

With this acquisition, Yatharth Hospital continues to strengthen its presence in the healthcare sector. The company currently operates multiple facilities across various locations including Greater Noida, Noida, Faridabad, New Delhi, and Madhya Pradesh. The addition of the Agra facility will further expand its geographical footprint and service capabilities.

The disclosure has been made available on the company's investor relations website at yatharthhospitals.com/investors, ensuring transparency and accessibility for stakeholders and investors.

Historical Stock Returns for Yatharth Hospital

1 Day5 Days1 Month6 Months1 Year5 Years
+2.70%-2.41%-1.19%-15.23%+80.28%+99.13%

More News on Yatharth Hospital

1 Year Returns:+80.28%